Besides NANOG and SOX9, we also revealed an up-regulation of OCT4, KLF4, and CD117 by HK2 in ovarian cancer, which further supports the concept that HK2 regulates CSCs. This evidence concerns the gene HK2 and ovarian carcinoma.